Skip to main content

SBC Medical Group Holdings Inc

corporate_fare Company Profile

SBC Medical Group Holdings Inc

SBC·NASDAQ·Industrial Applications And Services·CIK 0001930313

SBC Medical Group Holdings Incorporated provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore. The company offers a range of services including advertising and marketing across social media, staff recruitment and training, and booking reservations for franchisee clinic customers. It also assists with franchisee employee housing rentals, leasehold improvements, and design services for clinics, medical equipment, and medical consumables procurement. SBC Medical Group Holdings provides loyalty program management, labor and function support, management consulting, and IT software solutions. The company engages in franchising activities and distributes medical equipment, devices, implants, injection materials, other medical consumables, skin care and beauty products, and cosmetic products to franchisee clinics for resale. Its services encompass surgical and non-surgical cosmetic treatments such as breast augmentation, liposuction, rejuvenation treatments for wrinkles, acne, scars, cellulite, excess fat, discoloration, and aging signs, laser skin toning and spot removal, eyes double fold surgery, rhinoplasty, treatment of osmidrosis and hyperhidrosis, hair transplants, gynecological formation treatments, laser hair removal, face line surgeries, cosmetical dental procedures, tattoo removal, LASIK eye surgery, lateral canthoplasty, brow lift procedures, androgenetic alopecia treatment, and cheek sagging prevention methods. Additionally, SBC Medical Group Holdings owns and operates treatment centers under the SBC brand. The company was founded in 2000 and is headquartered in Irvine, California.

SBC Medical Group Holdings Inc (NASDAQ:SBC) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 21 items for SBC at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • SBC Medical Group Authorizes $20M Share Repurchase Program and Files $50M Shelf Registration

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$173.61M
Net Income
$50.99M
Diluted EPS
$0.50
Op. Cash Flow
$24.67M
Free Cash Flow
$23.27M
Gross Profit
$127.28M
Operating Income
$67.49M
Cash & Equivalents
$163.77M
Total Debt
$228.21K
Debt / Equity
0.00×
Net Margin
29.4%
Shares Outstanding
102.58M sh
Source: 10-K · filed 2026-04-30 · accession 0001493152-26-020748
$5.09
52-week range · as of 2026-08-13 $2.78 – $5.09
Market cap
$523.49M
Volume
167.1K (0.8× avg)
3-mo avg 203.7K
Live data · 2026-10-05 05:11 UTC · Market overnight

show_chartPrice Chart

Loading chart...

feed SBC - Filings & News (Page 2)

SBC
Jan 02, 2026, 8:35 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.31
Real-time Price: $5.09 info
Change: +$0.780 (+18%) info
Market Cap: $523.491M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets